Poultry and Swine : 1 kg per 1000 - 2000 litres of drinking water for 3 - 5 days
Making your decision: the practical framework After reviewing all the dosage data, side effects, timelines, and mechanisms, the decision between retatrutide and tirzepatide comes down to a handful of practical questions
Gorski JA, Balogh SA, Wehner JM, Jones KR (2003a)
(2000), Horm Res 53(Suppl 3), PubMed 10971106 Statistics from preclinical literature AOD-9604 = modified fragment of hGH 177191 + N-terminal Tyr (sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe), molecular weight 1815.1 Da Developed at Metabolic Pharmaceuticals (Australia) based on the work of professor Frank Ng (Monash University) in the 1990s Standard experimental dose in obesity clinical trials: 1 mg/day subcutaneously (Phase 2b, Heffernan et al.) Mechanism: stimulation of 3-adrenergic receptors in adipose tissue, increased lipolysis and fatty acid oxidation without activation of the hGH receptor (no IGF-1 increase) Phase 2b clinical trial (2007, 300 patients): weight reduction ~2.8 kg vs placebo over 12 weeks FDA status: NDI rejection (2014) as a dietary supplement
Journal of Pharmacological Sciences , 65(4), 89-96
Key Benefits: Brightens dull and tired skin for a radiant complexion Reduces the appearance of dark spots and hyperpigmentation Provides intense hydration and moisture retention Enhances skin elasticity and smoothness Acts as a calming and soothing mist for irritated skin Supports skin health with antioxidant-rich ingredients Formulated with glutathione and niacinamide , this essence helps diminish dark spots, brighten skin tone, and strengthen skin's barrier
